Flora Growth Corp

Flora Growth Corp. engages in the production of organic cannabis and pharmaceutical-grade medical products. It operates through the following segments: Cultivation, Processing, and Supplying of Natural, Medicinal-Grade Cannabis Oil and High Quality Cannabis; Over-the-Counter Medical Products and Medical Cannabis Products; Wellbeing Products; and Food and Beverage Products. The company was founded on March 13, 2019 and is headquartered in Toronto, Canada.

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Flora Growth Corp. engages in the production of organic cannabis and pharmaceutical-grade medical products. It operates through the following segments: Cultivation, Processing, and Supplying of Natural, Medicinal-Grade Cannabis Oil and High Quality Cannabis, Over-the-Counter Medical Products and Medical Cannabis Products, Wellbeing Products, and Food and Beverage Products. The company was founded on March 13, 2019 and is headquartered in Fort Lauderdale, FL.

FORT LAUDERDALE, Fla. & TORONTO--(BUSINESS WIRE)--Flora Growth Corp. (NASDAQ: FLGC) (“Flora” or the “Company”), a global cultivator, manufacturer, and distributor of cannabis products and brands, announces a change to the location of its annual and special meeting of shareholders to be held on June 6, 2023 at 9:00am Eastern Time (the “Meeting”). The new location for the Meeting will be at the offices of Greenberg Traurig, P.A. at 401 East Las Olas Boulevard Suite 2000, Fort Lauderdale, Florida.

Flora Growth Corp. Announces Change to Location of Annual and Special Meeting

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Flora Growth Corp. (NASDAQ: FLGC) (“Flora'' or the “Company”), a global cultivator, manufacturer, and distributor of cannabis products and brands, reported today its financial and operating results for the quarter ended March 31, 2023. All financial information is provided in U.S. dollars unless indicated otherwise. “As I take the reins of the organization, I am pleased to share the results of the first quarter of 2023, which included increased revenue ge.

Flora Growth Reports First Quarter 2023 Financial Results

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Flora Growth Corp. (NASDAQ: FLGC) (“Flora” or the “Company”) a leading cultivator, manufacturer and distributor of global cannabis products and brands, today announced that its board of directors (the “Board”) accepted the resignation of Luis Merchan as Chairman of the Board and the Company's Chief Executive Officer (CEO). To fill the vacancies created by Mr.

Flora Growth Corp. Announces the Appointment of Hussein Rakine as CEO and Member of the Board of Directors

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Flora Growth Corp. (NASDAQ: FLGC) (“Flora'' or the “Company”), a leading cultivator, manufacturer and distributor of global cannabis products and brands, announced today the certification of its Bogotá-based compound formulation laboratory, Flora Lab 4, following the required regulatory inspection by INVIMA (Colombia's FDA). The inspection certifies the lab as meeting Current Good Manufacturing Practices standards as determined by INVIMA.

Flora Growth Receives CGMP Certification of Compound Formulation Lab; Launches Prescription Cannabis Medicines in Colombia

Flora Growth Corp. (NASDAQ:FLGC ) Q4 2022 Earnings Conference Call April 3, 2023 8:00 AM ET Company Participants Jessie Casner - Chief Marketing Officer Luis Merchan - Chairman & Chief Executive Officer Elshad Garayev - Chief Financial Officer Conference Call Participants Aaron Grey - AGP Jessie Casner [Abrupt Start] Before we begin, I'd like to note that the webcast is being recorded and will be published for viewing shortly after the end of the webcast. On the call with me today are Luis Merchan, Chief Executive Officer and Chairman of the Board; as well as Elshad Garayev, Chief Financial Officer.

Flora Growth Corp. (FLGC) Q4 2022 Earnings Call Transcript

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Flora Growth Corp. (NASDAQ: FLGC) (“Flora'' or the “Company”), a leading cultivator, manufacturer and distributor of global cannabis products and brands, reported today its financial and operating results for the fiscal year ended December 31, 2022. All financial information is provided in U.S. dollars unless indicated otherwise. “In 2022, we not only met our revenue guidance but reported both quarterly and annual record revenue.

Flora Growth Reports 2022 Year-End Financial Results: $37.2M in Revenue, 314% Growth Year-Over-Year

FORT LAUDERDALE, Fla. & TORONTO--(BUSINESS WIRE)--Flora Growth Corp. (NASDAQ: FLGC) (“Flora'' or the “Company”), a leading cultivator, manufacturer and distributor of global cannabis products and brands, will host its 2022 year end earnings call via webcast on Monday, April 3, 2023 at 8:00 a.m. ET.

Flora Growth to Announce 2022 Year End Results April 3, 2023, at 8:00 a.m. ET

FORT LAUDERDALE, Fla. & TORONTO--(BUSINESS WIRE)--Flora Growth Corp. (NASDAQ: FLGC) (“Flora'' or the “Company”), a leading cultivator, manufacturer and distributor of global cannabis products and brands, announced today it has successfully begun distribution of its House of Brands product offering through the Juan Valdez coffeehouse chain. The agreement was signed with Procafecol S.A.

Flora Growth Begins Product Sales in Juan Valdez, Colombia's Largest Coffeehouse Chain

Flora Growth Corp. FLGC, stock rose 17% in premarket trades after the all-outdoor cultivator, manufacturer and distributor of cannabis products said it expects $90 million to $105 million in 2023 revenue. Analysts surveyed by FactSet are currently projecting $95.6 million in revenue for the company.

Microcap cannabis stock Flora Growth rallies on revenue view

FORT LAUDERDALE, Fla.--( BUSINESS WIRE )--Flora Growth Corp. (NASDAQ: FLGC) (“Flora'' or the “Company”), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, announced today revenue guidance of US$90 million to US$105 million for fiscal year 2023. Flora is also offering its shareholders and the general public a 2022 year-end recap of the global cultivator's growth and expansion highlights.

Flora Growth Issues 2023 Revenue Guidance of $90 Million to $105 Million Reflecting Anticipated Year Over Year Growth Exceeding 100%

FORT LAUDERDALE, Fla. & TORONTO--( BUSINESS WIRE )--Flora Growth Corp. (NASDAQ: FLGC) ("Flora" or the "Company"), a leading outdoor grower, manufacturer and distributor of cannabis products and brands worldwide, will host a webcast highlighting operational milestones achieved in 2022 which will take place on Monday, January 30th, 2023 at 4:30 p.m. ET.

Flora Growth to Host 2022 Year End Review Webcast January 30, 2023

FORT LAUDERDALE, Fla. & TORONTO--( BUSINESS WIRE )--Flora Growth Corp. (NASDAQ: FLGC) (“Flora'' or the “Company”), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, announced today it received an extension of 180 calendar days from the Nasdaq Stock Market LLC ("Nasdaq") to regain compliance with the Nasdaq's minimum $1.00 bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on the Nasdaq Capital Market (the "Bid Price Requirement"), following the expiration of the initial 180 calendar days period to regain compliance on January 4, 2023. The Nasdaq determination is based on the Company meeting the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on the Nasdaq Capital Market with the exception of the Bid Price Requirement, and the Company's written notice of its intention to cure the deficiency during the second compliance period by effecting a reverse stock split, if necessary.

Flora Growth Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule

FORT LAUDERDALE, Fla. & TORONTO--( BUSINESS WIRE )--Flora Growth Corp. (NASDAQ: FLGC) (“Flora'' or the “Company”), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, is pleased today to provide an update on commercial cannabis operations out of Colombia. Following the April 2022 passage of Resolution 539 permitting licensed cannabis cultivators with export quotas to export dry cannabis flower, Flora successfully exported nearly 1,000kgs of dried cannabis and derivatives to Europe and the United States in the fourth quarter of 2022. These activities are a part of the full commercialization of the Cosechemos farm and Flora Lab One facility in Bucaramanga, Colombia.

Flora Growth Provides Update to International Commercial Cannabis Export Business

Aurora Cannabis

AFC Gamma

Beyond Meat

Cara Therapeutics

Canopy Growth

Amplify Seymour Cannabis ETF

Cronos Group

Curaleaf Holdings, Inc.

Direxion Daily CSI China Internet Index Bull 2X Shares

GrowGeneration Corp

Green Thumb Industries Inc.

GW Pharmaceuticals

High Tide

Hydrofarm Holdings Group

Innovative Industrial Properties

Intercure Ltd

Amplify Alternative Harvest ETF

Cannabis REITs have been slammed this year amid concern over defaults from their cannabis cultivator tenants, which have been smoked by plunging wholesale cannabis prices and setbacks on federal legalization. The exclusion of the SAFE Banking Act from the omnibus federal spending package dimmed the once-high hopes that major federal marijuana legislation would be passed during the Biden Presidency.

Cannabis REITs: Smoked Out

FORT LAUDERDALE, Fla. & TORONTO--( BUSINESS WIRE )--Flora Growth Corp. (NASDAQ: FLGC) (“Flora'' or the “Company”), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, announced today, that, on December 23, 2022, it closed the previously disclosed acquisition of all of the issued and outstanding shares of Franchise Global Health Inc. (TSXV: FGH) (“FGH”), a multi-national operator in the medical cannabis and pharmaceutical industry, with principal operations in Germany.

Flora Growth Closes Acquisition of Franchise Global Health, Cementing Foothold in Germany and the European Union

Vancouver, British Columbia--(Newsfile Corp. - December 23, 2022) - Franchise Global Health Inc. (TSXV: FGH) ("Franchise Global" or the "Company"), a multi-national operator in the medical cannabis and pharmaceutical industry with principal operations in Germany, is pleased to announce that the Company and Flora Growth Corp.

Franchise Global Health Inc. Completes Plan of Arrangement with Flora Growth Corp.

FORT LAUDERDALE, Fla. & TORONTO--( BUSINESS WIRE )--Flora Growth Corp. (NASDAQ: FLGC) ("Flora'' or the "Company"), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, announced today that it has entered into securities purchase agreements with institutional investors for the purchase and sale of 12,500,000 of the Company's common shares, no par value (the “Common Shares”), pursuant to a registered direct offering (the “Offering”), and warrants to purchase up to 12,500,000 Common Shares (the “Warrants”). The combined purchase price for one Common Share and one Warrant will be $0.40. The Warrants will have an exercise price of $0.40 per Common Share, will be exercisable immediately following the date of issuance and will expire five years from the initial date of issuance.

Flora Growth Corp. Announces Pricing of $5.0 Million Registered Direct Offering

Flora Growth Corp. (NASDAQ:FLGC ) Q3 2022 Earnings Conference Call November 28, 2022 4:30 PM ET Company Participants Jessie Casner - Chief Marketing Officer Luis Merchan - President & CEO Elshad Garayev - CEO Jason Warnock - Chief Commercial Officer Conference Call Participants Jessie Casner Hello, everyone, and welcome to the Flora Growth Third Quarter 2022 Earnings Results Webcast. I'm Jessie Casner, Chief Marketing Officer at Florida Growth.

Flora Growth Corp. (FLGC) Q3 2022 Earnings Call Transcript

FORT LAUDERDALE, Fla. & TORONTO--( BUSINESS WIRE )--Flora Growth Corp. (NASDAQ: FLGC) (“Flora'' or the “Company”), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, reported today its financial and operating results for the third quarter and nine months ended September 30, 2022. All financial information is provided in U.S. dollars unless indicated otherwise.

Flora Growth Reports Third Quarter 2022 Financial Results

FORT LAUDERDALE, Fla. & TORONTO--( BUSINESS WIRE )--Flora Growth Corp. (NASDAQ: FLGC) (“Flora'' or the “Company”), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, will host its third quarter 2022 earnings call via webcast on Monday, November 28 at 4:30 p.m. ET.

Flora Growth Sets Third Quarter 2022 Conference Call for November 28, 2022, at 4:30 P.M. ET

FORT LAUDERDALE, Fla. & TORONTO--( BUSINESS WIRE )--Flora Growth Corp. (NASDAQ: FLGC) (“Flora'' or the “Company”), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, announced today the completion of its new laboratory, specializing in the manufacturing of compound formulations utilizing cannabis derivatives and traditional master formulas. Located in Bogota, Colombia, Flora Lab 4 will become part of Flora's group of laboratories including existing labs that produce cosmetics, phytotherapeutic products, dietary supplements, and cannabis extraction and transformation.

Flora Growth Completes Construction of Laboratory, Specializing in Prescription Cannabis Formulations

Flora Growth Announces Shareholders Owning Over 73% of Shares of Franchise Global Health Support Acquisition by Flora

Flora Growth to Host Webcast Discussing M&A Activity and International Market Opportunities - Wednesday, October 26, 2022

Flora Growth Corp. FLGC, +3.65% said Monday it would issue up between 36.62 million and 43.53 million common shares to acquire Franchise Global Health Inc. FGH, +12.50% a multi-national medical cannabis and pharmaceutical operator with principal operations in Germany. Based on Flora Growth's share price of 53 cents on Friday, the deal is currently valued at up to $23.5 million in stock.

Flora Growth buys Franchise Global Health in all-stock cannabis deal in German market

Flora Growth Signs Definitive Agreement to Acquire Franchise Global Health, a Prominent Pharmaceutical and Medical Cannabis Distributor with Principal Operations in Germany

News for Flora Growth Corp Stock (FLGC)